Pharma manufacturers and their logistics partners always need to stay up to date with the legalities of aviation transport – and particularly legislation relating to (bio)pharmaceuticals. Not only that, exporting pharma products worldwide means being aware of many different jurisdictions at the same time.
Being ready to tackle any possible issues that might arise is crucial for your business. Luckily, the latest speaker to take part in FlyPharma Europe – Philip Graff from Bird & Bird – is preparing to offer his advice on ‘Legal and contractual issues regarding the air transportation of pharma products’. His presentation on 22 October will cover the following areas:
• Are the rules and contract practices up to date?
• Latest developments and interesting case law
• Risk allocation between the involved parties
With extensive knowledge of air transport of pharma products, and having represented a number of major freight forwarders and airlines over the years, you don’t want to miss his session at FlyPharma Europe.
Philip Graff is a partner in Bird & Bird, a leading international law firm within aviation and life science. With more than 30 years’ experience in law and transportation, Philip has seen the development of air transportation of pharma products and is well-placed to advise on the future of the industry.